Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionHsbc Holdings Plc
Latest Disclosed Ownership55,549 shares
Latest Disclosed Value $ 1,220,329
Hsbc Holdings Plc ownership in SRPT / Sarepta Therapeutics, Inc.

On April 30, 2026 - Hsbc Holdings Plc filed a 13F-HR form disclosing ownership of 55,549 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $1,220,329 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 20, 2026 disclosing 33,548 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 65.58% during the quarter.

Hsbc Holdings Plc has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 55,549 22,001 65.58 1,220 68.04 0.0006
2026-03-20 2025-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 33,548 -12,041 -26.41 727 -13.37 0.0004
2026-03-06 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 33,548 -12,041 727 0.0000
2025-11-13 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 45,589 -35,089 -43.49 839 -39.58 0.0005
2025-08-13 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 80,678 -23,022 -22.20 1,387 -79.04 0.0008
2025-05-14 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 103,700 -76,853 -42.57 6,618 -69.78 0.0041
2025-02-14 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 180,553 21,914 13.81 21,901 10.32 0.0127
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 158,639 156,281 6,627.69 19,852 5,250.94 0.0116
2024-08-12 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 2,358 -47,489 -95.27 372 -94.24 0.0002
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 49,847 21,334 74.82 6,445 134.45 0.0044
2024-02-12 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 28,513 25,998 1,033.72 2,750 804.28 0.0024
2023-11-13 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 2,515 519 26.00 305 33.33 0.0003
2023-08-11 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 1,996 -16,780 -89.37 228 -91.26 0.0002
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 18,776 4,341 30.07 2,610 42.03 0.0031
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 14,435 14,435 1,837 0.0021
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -74,576 -100.00 0 -100.00
2022-08-11 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 74,576 70,140 1,581.15 5,700 1,523.93 0.0080
2022-05-16 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 4,436 -450 -9.21 351 -20.77 0.0004
2022-02-11 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 4,886 4,886 443 0.0004
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -6,105 -100.00 0 -100.00
2021-08-13 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 6,105 -15,660 -71.95 479 -70.41 0.0005
2021-05-14 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 21,765 8,754 67.28 1,619 -27.04 0.0019
2021-02-25 2020-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 13,011 2,301 21.48 2,219 46.28 0.0030
2021-02-12 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 8,451 -2,259 1,445 343.0961
2020-11-12 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 10,710 8,387 361.04 1,517 307.80 0.0024
2020-08-14 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 2,323 -4,243 -64.62 372 -42.15 0.0007
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 6,566 6,566 643 0.0015
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -3,572 -100.00 0 -100.00
2019-08-13 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 3,572 -734 -17.05 543 5.85 0.0010
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 4,306 4,306 513 0.0009
2018-08-10 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -3,110 -100.00 0 -100.00
2018-05-11 2018-03-31 13F SAREPTA THERAPEUTICS COM 803607100 3,110 -554 -15.12 230 13.30 0.0003
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM 803607100 3,664 3,664 203 0.0003
2017-05-15 2017-03-31 13F SAREPTA THERAPEUTICS COM 803607100 0 -8,750 -100.00 0 -100.00
2017-02-09 2016-12-31 13F SAREPTA THERAPEUTICS COM 803607100 8,750 8,750 240 0.0006
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-14 2025-03-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F SAREPTA THERAPEUTICS COM Put 100,000 12,107 n/a n/a n/a
2021-05-14 2021-03-31 13F SAREPTA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-12 2020-12-31 13F SAREPTA THERAPEUTICS COM Put 4,560 774 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.